Menu
Home
Conferences
Collections
Calls for Papers
MSF Research Ethics
Clinical Case Reporting
About
My Saved Content
Science Portal
Advanced Search
My Saved Content
Browse All
Conferences
Collections
Calls for Papers
MSF Research Ethics
Clinical Case Reporting
About
English
Conference Material
|
Video
Feasibility and acceptability of single-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis in low-resource settings: The AmbiOne mixed-methods study
Falconer J
Save
Cite
Share
Countries
Democratic Republic of Congo
Guinea
Mozambique
Subject Area
infections, other
HIV/AIDS
cryptococcal meningitis
Languages
English
Published Date
20 May 2026
Conference
MSF Scientific Days International 2026
Linked Content
Conference Material
|
Slide Presentation
Feasibility and acceptability of single-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis in low-resource settings: The AmbiOne mixed-methods study
2026 May 20 • MSF Scientific Days International 2026
Conference Material
|
Abstract
Feasibility and acceptability of single-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis in low-resource settings: The AmbiOne mixed-methods study
2026 May 20 • MSF Scientific Days International 2026
Similar Content
Slide Presentation
|
Slide Presentation
Feasibility and acceptability of single-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis in low-resource settings: The AmbiOne mixed-methods study
2026 May 20 • MSF Scientific Days International 2026
Abstract
|
Abstract
Feasibility and acceptability of single-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis in low-resource settings: The AmbiOne mixed-methods study
2026 May 20 • MSF Scientific Days International 2026
Loading...
Save
Cite
Share
